Table 4.
The multiple linear regression model about voriconazole trough concentration 2.
| Variable | Unstandardized Coefficients | Standardized Coefficients | t | p-Value | VIF | |
|---|---|---|---|---|---|---|
| B | Std. Error | |||||
| Intercept | 1.760 | 0.849 | - | 2.072 | 0.041 | - |
| Daily dose | 0.012 | 0.002 | 0.439 | 5.236 | 0.000 | 1.069 |
| PTA | −0.036 | 0.012 | −0.238 | −3.139 | 0.002 | 1.038 |
| Sex | 1.602 | 0.598 | −0.217 | 2.645 | 0.009 | 1.064 |
| CYP2C19 genotyping 1 | ||||||
| *1/*2 | 0.266 | 0.428 | 0.053 | 0.622 | 0.535 | 1.192 |
| *1/*3 | 1.252 | 0.733 | 0.140 | 1.708 | 0.090 | 1.121 |
| *2/*2 | 1.492 | 0.596 | 0.209 | 2.503 | 0.014 | 1.166 |
| F = 9.686 | <0.001 | |||||
1 Compared to CYP2C19*1/*1, dealt with the operation of dummy variables. 2 R2 = 0.348; Durbin–Watson test value = 1.801; 115 voriconazole trough concentrations were selected and analyzed.